Robocath Companies
Rouen, France, November 30, 2021 – Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, today announces the successful completion of the first coronary angioplasty in China assisted by its R-One™ robotic platform.
%20.jpg)
.png)
Total Funding:
56219416
Technology:
Biotechnology, Health Care, Medical, Robotics
Estimated Revenue:
$1M to $10M
Employee Number:
11-50
Industry:
Health Care Equipment
Founded Date:
2009-01-01
Headquarters:
Rouen, Haute-Normandie, France
Last Funding Date:
2020
Last Funding Type:
Series C
Funding Status:
Late Stage Venture